Transient inhibition of ROR-?t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nm.4046
PubMed Identifier: 26878233
Publication URI: http://europepmc.org/abstract/MED/26878233
Type: Journal Article/Review
Parent Publication: Nature Medicine
Issue: 3
ISSN: 1078-8956